Works by Schär, Sämi


Results: 14
    1
    2

    Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R‐CHOP14: A SAKK 38/07 trial post‐hoc analysis.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 1, p. 11, doi. 10.1002/hon.2935
    By:
    • Ceriani, Luca;
    • Milan, Lisa;
    • Cascione, Luciano;
    • Gritti, Giuseppe;
    • Dalmasso, Federico;
    • Esposito, Fabiana;
    • Pirosa, Maria Cristina;
    • Schär, Sämi;
    • Bruno, Andrea;
    • Dirnhofer, Stephan;
    • Giovanella, Luca;
    • Hayoz, Stefanie;
    • Mamot, Christoph;
    • Rambaldi, Alessandro;
    • Chauvie, Stephane;
    • Zucca, Emanuele
    Publication type:
    Article
    3

    Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 715, doi. 10.1002/hon.2805
    By:
    • Zucca, Emanuele;
    • Cascione, Luciano;
    • Ruberto, Teresa;
    • Facchinelli, Davide;
    • Schär, Sämi;
    • Hayoz, Stefanie;
    • Dirnhofer, Stefan;
    • Giovanella, Luca;
    • Bargetzi, Mario;
    • Mamot, Christoph;
    • Ceriani, Luca
    Publication type:
    Article
    4
    5

    Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1605, doi. 10.1007/s00262-020-02565-0
    By:
    • Schmid, Sabine;
    • Mauti, Laetitia A.;
    • Friedlaender, Alex;
    • Blum, Veronika;
    • Rothschild, Sacha I.;
    • Bouchaab, Hasna;
    • Frösch, Patrizia;
    • Britschgi, Christian;
    • König, David;
    • Wannesson, Luciano;
    • Janthur, Wolf-Dieter;
    • Schär, Sämi;
    • Demmer, Izadora;
    • Addeo, Alfredo;
    • Jochum, Wolfram;
    • Früh, Martin
    Publication type:
    Article
    6
    7
    8

    Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study †.

    Published in:
    Cancers, 2022, v. 14, n. 4, p. 1018, doi. 10.3390/cancers14041018
    By:
    • Genta, Sofia;
    • Ghilardi, Guido;
    • Cascione, Luciano;
    • Juskevicius, Darius;
    • Tzankov, Alexandar;
    • Schär, Sämi;
    • Milan, Lisa;
    • Pirosa, Maria Cristina;
    • Esposito, Fabiana;
    • Ruberto, Teresa;
    • Giovanella, Luca;
    • Hayoz, Stefanie;
    • Mamot, Christoph;
    • Dirnhofer, Stefan;
    • Zucca, Emanuele;
    • Ceriani, Luca
    Publication type:
    Article
    9
    10
    11
    12

    P-227: Alternate day dosing of pomalidomide in patients with refractory/relapsed multiple myeloma (RRMM): Results of a multicenter, single arm phase 2 trial (SAKK 39/16 OptiPOM Study).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S165, doi. 10.1016/S2152-2650(21)02354-5
    By:
    • Zander, Thilo;
    • Pabst, Thomas;
    • Schär, Sämi;
    • Aebi, Stefan;
    • Pabst, Tobias;
    • Mey, Ulrich;
    • Novak, Urban;
    • Lerch, Erika;
    • Rhyner, Gaëlle;
    • Goede, Jeroen;
    • Maniecka, Zuzanna;
    • Hayoz, Stefanie;
    • Rufer, Axel;
    • Renner, Christoph;
    • Driessen, Christoph
    Publication type:
    Article
    13
    14